Polyethylene glycol-interferon alpha conjugates for therapy...

Details Polyethylene glycol-interferon alpha conjugates for therapy... Polyethylene glycol-interferon alpha conjugates for therapy...

A - Human Necessities

61

K

A61K 47/48 (2006.01)

Patent

CA 2288038

A method comprising administering a PEG12000-IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.

Cette invention se rapporte à un procédé consistant à administrer un conjugué PEG¿12000?-IFN alpha à un individu souffrant d'une infection virale susceptible d'être traitée avec de l'interféron alpha, cette infection étant de préférence l'hépatite C chronique.

Affiliated with

Also associated with

Rating

Polyethylene glycol-interferon alpha conjugates for therapy... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyethylene glycol-interferon alpha conjugates for therapy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyethylene glycol-interferon alpha conjugates for therapy... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1845962